Navigation Links
MannKind Corporation Reports Second Quarter Financial Results
Date:8/11/2008

2008 2007 2008 2007

Revenue $ - $ - $20 $10

Operating expenses:

Research and development 67,574 61,480 126,019 125,268

General and administrative 13,290 13,913 28,930 27,463

Total operating expenses 80,864 75,393 154,949 152,731

Loss from operations (80,864) (75,393) (154,929) (152,721)

Other income (expense) (60) 44 - 96

Interest expense on senior

convertible notes (124) (901) (461) (2,046)

Interest income 1,222 4,261 4,143 9,541

Loss before provision for

income taxes (79,826) (71,989) (151,427) (145,130)

Income taxes - - - -

Net loss $(79,826) $(71,989) $(151,247) $(145,130)

Net loss per share -

basic and diluted $ (0.79) $ (0.98) $ (1.49) $ (1.98)

Shares used to compute basic

and diluted net loss

per share 101,427 73,421 101,418 73,405

MannKind Corporation

Condensed Balance Sheet

(Unaudited)

(in thousands)

June 30, December 31,

Assets 2008 2007

Current assets:

Cash and cash equivalents $180,454 $368,285

State research and development tax credit

exchange receivable - current - 831

Prepaid expenses and other current assets 7,253 9,596

Total current assets 187,707 378,712

Propert
'/>"/>

SOURCE MannKind Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 11, 2008
2. MannKind to Present at Upcoming Conferences
3. MannKind Corporation Reports First Quarter Financial Results
4. MannKind to Present at the Morgan Stanley Healthcare Conference
5. MannKind Corporation to Hold First Quarter Financial Results Conference Call on May 5, 2008
6. Matthew J. Pfeffer Joins MannKind as Corporate Vice President and Chief Financial Officer
7. MannKind Corporation Response to Recent Market Events
8. MannKind Corporation to Hold Fourth Quarter Financial Results Conference Call on March 4, 2008
9. MannKind to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
10. MannKind to Present at the Wachovia 2008 Healthcare Conference
11. MannKind to Present at the Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... CITY , July 28, 2015 /PRNewswire/ - Aeterna ... today announced that it has granted to German ... funding the development and commercialization of biotechnology (collectively, ... live recombinant oral allogenic tumor vaccine technology (the ... for prostate cancer which is ready to enter ...
(Date:7/27/2015)... THOUSAND OAKS, Calif. , July 27, 2015 /PRNewswire/ ... will report its second quarter financial results on Thursday, ... financial markets. The announcement will be followed by a ... PT. Participating in the call from Amgen will be ... officer, and other members of Amgen,s senior management team. ...
(Date:7/27/2015)... ... , ... Production of high tenacity filament yarn of viscose rayon (excluding sewing ... instance, it surpassed the EUR 106 million mark (in value terms) in 2013, while ... major producer, while Italy is a key consumer. , The high tenacity filament ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... network Monday. The venture will bring the world’s most efficient gas dissolution technology ... equipment and technologies to both the industrial and municipal markets. With offices located ...
Breaking Biology Technology:Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 3Amgen Announces Webcast of 2015 Second Quarter Financial Results 2High Tenacity Filament Yarn of Viscose Rayon Consumption to Grow Swiftly in the EU, Forecasts BAC Reports in New Study Available at MarketPublishers.com 2BlueInGreen Brings Water Treatment Technology to Florida 2
... to the anterior cruciate ligament (ACL) is fairly common, ... corrected through surgery, the injury can lead to increased ... The problem is that fluid in the knee joint, ... of the injury and begins to deteriorate. A new ...
... DENVER , Aug. 5 Forensic ... services for drug and alcohol abuse, has announced the ... is the first lab in the nation to develop ... in saliva, a chemical produced by the body after ...
... Oncimmune® (USA) LLC , provider of Early ... and the early detection of lung cancer , today announced ... the test. The study titled " Clinical Validation of an Autoantibody ... at Annals of Oncology , Oxford Journals, or at Oncimmune,s ...
Cached Biology Technology:Lubricating the knee cartilage after ACL injury may prevent osteoarthritis 2Lubricating the knee cartilage after ACL injury may prevent osteoarthritis 3Forensic Laboratories Develops First Oral Fluid Test for Ethyl Sulfate Detection 2New Study Demonstrates Clinical Validity of EarlyCDT-Lung™ 2New Study Demonstrates Clinical Validity of EarlyCDT-Lung™ 3New Study Demonstrates Clinical Validity of EarlyCDT-Lung™ 4New Study Demonstrates Clinical Validity of EarlyCDT-Lung™ 5New Study Demonstrates Clinical Validity of EarlyCDT-Lung™ 6
(Date:7/21/2015)... Sweden , July 21, 2015 Today, ... FPC1025. Already received as well as expected revenues in 2015 that ... in FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a leading smartphone manufacturer in China ... selected FPC1 02 5 for Axon ...
(Date:7/13/2015)... 13, 2015 Synaptics Inc. (NASDAQ: ... solutions, today announced sampling of ClearPad ® ... integration (TDDI) product targeting smartphones and tablets. This ... Synaptics , best-in-class touch controller IP and ... developed in the company,s Japan Design Center. TDDI ...
(Date:7/9/2015)... , July 9, 2015  Unchained Labs just ... its acquisition of Avid Nano. Avid Nano designs, ... (DLS) systems.    Also today, Unchained ... and easiest to use protein sizing system. The ... a protein,s hydrodynamic size, size distribution, aggregation population ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2
... postmenopausal women and people of all ages, actually ... solution to help prevent fractures and osteoporosis: eating dried plums. ... figs, dates, strawberries and raisins, and none of them come ... dried plums, or prunes, have," said Bahram H. Arjmandi, Florida ...
... cloud computing becomes the next big consumer techo trend, ... physically store everything from playlists to photos, it,s ... is done. Using the cloud model as inspiration, biomedical ... the Translational Research Informatics and Data management grid (TRIAD), ...
... partnering organizations have discovered a remarkably primitive eel in a ... This fish exhibits many primitive anatomical features unknown in the ... eels, resulting in its classification as a new species belonging ... published online in the Proceedings of the Royal Society ...
Cached Biology News:No bones about it: Eating dried plums helps prevent fractures and osteoporosis 2Biomedical research gets its head into cloud computing 2Biomedical research gets its head into cloud computing 3Biomedical research gets its head into cloud computing 4Scientists discover the most primitive living eel 2
RAT ANTI MOUSE METALLOPHILIC MACROPHAGES...
... Ferrofluid products perform optimally when ... Systems MagCellect Magnet. To accommodate ... iron boron permanent magnet holds ... mm test tubes or two ...
Request Info...
Form: Concentrated Applications: ELISA...
Biology Products: